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In this chapter, the total synthesis of (R, R, R)-γ-tocopherol is described. Starting from 
2,3-dimethylhydroquinone and phytol, (R, R, R)-γ-tocopherol was synthesized in 36% yield over 12 
steps (longest linear sequence), based on the copper (I) catalysed 1,2-addition of Grignard 




















Parts of this chapter have been published: 
 










Vitamins are essential food ingredients for humans and in feed for animal 
husbandry. The most important fat-soluble antioxidant, vitamin E, was first reported 
about one century ago,[1] and is of particular industrial interest as a food and feed 
additive.[2] Although formally vitamin E comprises a family of tocopherols and 
tocotrienols with a chroman core (Figure 1), in practice the term is synonymous with 
α-tocopherol or its acetate as it is by far the most dominant member.[2a, 3] 
All-rac-α-tocopherol is produced on a scale of more than 30,000 ton per year.[4] To 
meet this huge demand of vitamin E, the industrial synthesis is accomplished by the 
condensation of trimethylhydroquinone (9) and chemically produced isophytol 10. 












































Figure 1. Vitamin E 
 
The naturally occurring (R,R,R)-tocopherols are biologically the most active,[3, 6] 
and in particular the stereochemistry at C2 is important.[7] Consequently, the 
asymmetric synthesis of 1, and especially the stereoselective synthesis of the chroman 
core,[8] has been the topic of intense research, which has been discussed in several 
reviews.[9] A selection of the more recent approaches in asymmetric catalysis is 
depicted in Scheme 2.[10] A very recent shoot of this tree is the application of the 
Ni-catalyzed conjugate addition of methyl organometallics to a 2-alkyl-4-chromenone 
core providing the racemic product unfortunately. Later, the high 
(2R)-stereoselectivity was achieved by the same group via an asymmetric 1,4-addition 
of AlMe3 to the activated 2-substituted chromenone in the presence of a chiral 
Cu(I)-phosphoramidite complex as a catalyst.[11] 
γ-Tocopherol is another major member of the vitamin E family and the main 
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vitamin E in US diet. Although α-tocopherol has the highest vitamin E activity,[7] 
γ-tocopherol has an unsubstituted aromatic position and therefore can trap 
electrophilic mutagens, such as nitronium ions,[12] more efficiently.[13] This has 





























































Barrier et al, 1990
 
Scheme 2. Recently reported strategies on the stereoselective construction of the 
2R-chroman core in the synthesis of 1[15] 
 
Compared to α-tocopherol, synthesis efforts on (R,R,R)-γ-tocopherol 3 have been 
particularly scarce, and the first total synthesis of γ-tocopherol was reported in 1994 
with a copper mediated coupling methodology.[9a, 9d][16] In 1997, Habicher et al. 
prepared γ-tocopherol by photodecarboxylation of γ-tocopherol-5-carboxylic acid, in 
turn derived from α-tocopherol.[17] Based on this aryl demethylation approach of 
α-tocopherol, Salvadori et al. reported the preparation of labeled and unlabeled 
(R,R,R)-γ-tocopherol 3.[18] No catalytic asymmetric synthesis of 3 has been reported. 
 
3.2 Retrosynthetic strategy for (R,R,R)-γ-tocopherol 3 
In 2012, we reported the enantioselective 1,2-addition of Grignard reagents to 




leads to chiral enantioenriched tertiary allylic alcohols, and in Chapter 2 is described 













94% yield, 90% ee  
Scheme 3. An example of the asymmetric Cu-catalyzed 1,2-addition of Grignard 
reagents to enones 
We realized that this catalytic asymmetric 1,2-addition could function as a 
cornerstone for a novel, relatively straightforward approach to tocopherols and 
tocotrienols provided the subsequent ring closure to the chroman nucleus would be 
racemization-free. This requires either a strictly SN2-type nucleophilic substitution of 
the tertiary alcohol by the aromatic hydroxyl group, or an aromatic alkoxylation 
reaction. The latter, proceeding via an oxidation-reduction pathway of the 
hydroquinone, had been discovered and studied in depth already by Cohen et al. and 
does not lead to erosion of e.e.,[21] (Scheme 4) as confirmed by subsequent studies.[10c, 
22] Based on these two key steps, a retrosynthesis was designed allowing full freedom 
both in the substitution pattern (α, β, γ, δ)- of the aromatic ring and in the chain 





















Scheme 4. Mechanism of the cyclization leading to vitamin E 
 
Aiming at γ-tocopherol, in the synthesis direction ketone 13 should be accessible 
from commercially available 2,3-dimethyl hydroquinone 15. As the copper-catalyzed 
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asymmetric Grignard addition requires both an unsaturation and an α-substituent 
flanking the carbonyl group, subsequent steps should lead to 12 (Scheme 5). We 
showed already that after the 1,2-addition, the auxiliary Br is readily removed via Li 
halogen exchange followed by protonation. Also reduction of the alkene was not 
expected complicated provided hydrogenolysis of the hydroxyl group could be 
suppressed. For the actual copper-catalyzed asymmetric 1,2-addition, the current 
method would have to be advanced. Substrates containing heavily substituted phenyl 
groups had not been studied in this reaction and therefore the influence of these 
substitutions on the chemo-, regio-, and enantioselectivity was not known. Moreover, 
the required Grignard reagent 14 is a long chain with the nearest branch at the 
δ-position, whereas in the current catalyst system high e.e.’s were obtained solely with 
β-branched Grignard reagents such as iso-butylmagnesium bromide (see Scheme 3). 
Although efficient catalytic strategies for the asymmetric synthesis of so-called 
saturated polyisoprenoids have been developed both by Pfaltz et al.[23] and by us,[24] 


























Scheme 5. Retrosynthesis of (R,R,R)-γ-tocopherol 3 
 
3.3 Results and discussion 
The synthesis of 13 is summarized in Scheme 6. An attempted formylation of 15 
according to Skattebøl et al. (with paraformaldehyde, MgCl2 and triethylamine)[26] did 
not provide the desired aldehyde; not unexpected as this reaction has not been 
reported with hydroquinones as substrate. Therefore, 16 was prepared in quantitative 
yield.[27] A direct formylation of 16 turned out to be very difficult as well. Duff 
reaction (hexamine and TFA) with 16 has been reported[28] to afford 18 in 44% yield, 
a result that was reproduced but not improved. Vilsmeier-Haack reaction (phosphoryl 
chloride and DMF),[29] Rieche formylation (titanium tetrachloride and dichloromethyl 




with DMF[31] did not provide significant amounts of 18. In an alternative approach, 
using the conditions reported by Fukuyama et al., 16 was first brominated,[32] 
followed by bromo lithium exchange and reaction with DMF.[33] This led after 
optimization to 18 in an excellent yield from 16. Then, 18 was transformed into enone 
19 by aldol condensation with acetone in 96% yield.[34] Subsequent 
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Scheme 6. Synthesis of 13: a) MeI, NaH, DMF, 0 ºC to r.t., 3 h; b) NBS, CH2Cl2, 
reflux, overnight, 93% over two steps; c) nBuLi, DMF, THF, –78 ºC, 0.5 h, 92%; d) 
acetone, NaOH, EtOH, r.t., 10 min, 96%; e) NaBr, oxone, CH2Cl2/H2O, 0 ºC to r.t., 
overnight; f) Et3N, THF, reflux, overnight, 80% over two steps. 
 
The preparation of Grignard reagent 14 started from phytol 21 which already 
contains two chiral centers with the desired absolute configuration (Scheme 7). 
Ozonolysis of phytol led to ketone 22,[36] which was followed by Baeyer-Villiger 
oxidation according to the procedure of Pratt and Porter et al. to give 23.[37] After 
hydrolysis of the acetate, 24 was isolated in 92% yield over 3 steps. Bromination gave 
the desired 25 in 76% yield from 24.[38] This bromide was converted into its 
corresponding Grignard reagent 14 as an ≈ 1.5 M solution in ether.  
With both 13 and 14 in hand, the copper catalyzed asymmetric 1,2-addition was 
studied. Applying the established conditions (Scheme 3) and Grignard reagent 14, 
tertiary alcohol 26 was obtained in very good yield. The diastereoselectivity however 
(as the Grignard reagent itself is chiral enantiopure, the stereoselectivity in the formed 
chiral center is expressed as d.e.), was only 42% (Table 1, entry 1). Screening various 
solvents, e.g. diethyl ether, diisopropyl ether, 1,2-dimethoxyethane, and cyclopentyl 
methyl ether, as well as applying a prolonged addition time, or portion-wise addition 
of 13 and 14 did not improve this result. To benchmark the obtained 42% d.e., the 
asymmetric addition of isobutylmagnesium bromide to 13 was carried out as well, 
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which provided 27 in a rewarding 87% e.e. (entry 2). This strongly suggested that the 
moderate d.e. in the case of 26 is not due to the substitution pattern of the phenyl ring 
but due to the structure of the Grignard reagent 14. That there are boundaries at the 
substitution pattern on the aromatic ring of the substrate became clear in a parallel 
study. When the methyl protecting groups in 13 were replaced by 
tertbutyldimethylsilyl groups leading to enone 28, this substrate did not react under 
standard 1,2-addition conditions (entry 3). Also 29 was prepared as the precursor for 



















Scheme 7. Synthesis of 14: a) Ozone, CH2Cl2/MeOH, –78 ºC; b) (CF3CO)2O, 
Na2CO3.1.5 H2O2, CH2Cl2, r.t., 2 d; c) LiOH, THF/MeOH/H2O, r.t., 2 h; 92% over 
three steps; d) NBS, PPh3, CH2Cl2, 0 ºC, 2 h, 76%; e) Mg, Et2O. 
 
These studies forced a re-evaluation of the applied chiral ligand, rev-Josiphos L1. 
In the development of the catalytic asymmetric 1,2-addition of Grignard reagents we 
had already experienced that L1 was unique in its chiral induction. Both closely 
related ligands such as the parent Josiphos, and unrelated ligands such as BINAP, and 
phosphoramidites performed badly. These studies were carried out with 
iso-butylmagnesium bromide as the nucleophile. 
We therefore studied various chiral ligands, including the commercial ligands L2-4 
and L8-9 and the ligands L5-7 prepared for this purpose,[39][40] in combination with 
Grignard reagent 14. Most ligands performed less well compared to rev-Josiphos L1 
(entry 5-10). Josiphos-type ligand L8, being an exception, afforded a virtually 
identical d.e. as L1 (entry 11). L8 bears a sterically demanding di-tert-butyl 
phosphine group in combination with the Josiphos-like arrangement of a di-alkyl 
phosphine on the ethyl branch and a diarylphosphine on the ferrocene ring. In our 
experience, the enantioselectivity of the copper catalyzed 1,2-addition profits from 
rev-Josiphos type ligands, that is, a di-alkyl phosphine on the ferrocene and a 








































Entry R1 R2 R3 Ligands d.e./e.e.[a]
Me H C16H33*[b] L1 42
Me H (CH3)2CHCH2 L1 87
TBS H C16H33* -
Me Me L1 7C16H33*
Me H C16H33* L8 43
Me H C16H33* L2 36
Me H C16H33* L3 7
Me H C16H33* L4 12
Me H C16H33* L5 racemic
Me H C16H33* L6 racemic
Me H C16H33* L9 73

























































To our delight, a significant improvement of the diastereoselectivity to 73% was 
observed in the 1,2-addition of Grignard reagent 14 to 13 (entry 12). So, the 3 
rev-Josiphos-type ligands L7, L1, and L8, gave us a clear hint to increase the d.e. in 
the 1,2-addition of 14 to 13, by increasing the steric bulk at the ferrocene phosphorus 
substituent of rev-Josiphos type ligands. This lured us into an attempt to prepare 
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several new rev-Josiphos type ligands with sterically very hindered phosphorus 
substituents on position 2 of the ferrocenyl ring (Figure 2). A considerable effort was 
invested in the preparation of L1-type ligands with R = EtMe2C, Et3C, iPrMe2C, and 
adamantyl according to literature procedures for related ligands.[41] However, the 
coupling of the R2PCl reagent with the ortho-lithiated ferrocene invariably failed, 
probably due to this (desired) steric hindrance. Ligand L7 was accessible via this 
method but afforded a low d.e. in the subsequent 1,2-addition, probably because the 
steric bulk was not directly positioned at the phosphorus center. Therefore we had to 






than a tert-butyl group
R =
 
Figure 2. Designed rev-Josiphos type ligands. 
 
With the most optimal ligand L9, we produced the key chiral tertiary alcohol 26 in 
73% d.e. and 93% yield (Scheme 8, the appropriate enantiomer of L9 was chosen 
based on Chapter 2, which turned out to be correct, vide infra). Straightforward 
debromination of 26 with tBuLi at –78 ºC for 0.5 h afforded 31 in 91% yield.[42] 
Reduction of the double bond in 31 turned out to be a showcase for flavine-catalyzed 
diimide reduction.[43] Heterogeneous transition metal catalysts, e.g. Pd/C,[44] Pt/C, 
PtO2,[45] and Pd/C/NaOAc,[10c] in combination with H2 invariably provided the 
hydrogenolysis product, and also the recently disclosed diimide reduction with FeCl3 
as the catalyst suffered from hydrogenolysis.[46] Flavine-catalyzed double bond 
reduction of 31 afforded 32 as the only product in 90% yield.[47] To prepare for the 
ringclosing step, 32 was oxidized to the corresponding quinone by treatment with 
cerium(IV)ammonium nitrate, followed by subsequent reduction to afford 
hydroquinone 11. Finally, acid-catalyzed and oxygen-induced cyclization of 11 
provided the desired (R,R,R)-γ-tocopherol 3 in 72% yield over three steps.[22b, 22c] The 
synthetic material was identical in all aspects (1H- and 13C-NMR, mass analysis) with 
































Scheme 8. Synthesis of (R,R,R)-γ-tocopherol. a) 14, CuBr⋅SMe2, L9, TBME, –78 ºC, 
overnight, 93%; b) tBuLi, Et2O, –78 ºC, 0.5 h, 91%; c) flavin catalyst, O2, N2H4⋅H2O, 
EtOH, r.t., overnight; 90%; d) i. Ce(NH4)2(NO3)6, THF/H2O, 0 ºC, 0.5 h; ii. Na2S2O4, 
acetone/H2O, r.t., 0.5 h; e) p-TSA, toluene, 60 ºC, 5 min, 72% over three steps.  
 
3.4 Conclusion 
In summary, we developed an efficient synthesis of (R,R,R)-γ-tocopherol based on 
copper catalyzed asymmetric 1,2-addition. Starting from commercially available 
2,3-dimethyl hydroquinone and natural phytol, (R,R,R)-γ-tocopherol was prepared in 
12 steps (longest linear sequence), 36% overall yield and 73% d.e. at the C2 chiral 
center. The synthesis is not misplaced in the current collection of catalytic asymmetric 
approaches to the tocopherols, as the route is straightforward, in particular in its 
introduction of chirality at C2, and its use of readily available building blocks. An 
important finding is that the catalyst system used for the asymmetric addition of a 
complex Grignard reagent could be considerably optimized in terms of 
stereoselectivity. This means that the scope of Grignard reagents suitable for this 
reaction has been enlarged and invites to further study this direction. Inherently the 
method is very versatile as Grignard reagents are readily prepared from alkyl 
bromides. 
 
3.5 Experimental section 
General remarks: 1H-NMR and 13C-NMR spectra were recorded on a Varian AMX400 
(400 and 100 MHz, respectively) with CDCl3 as solvent. Chemical shifts were 
determined relative to the residual solvent peaks (CHCl3, δ = 7.26 ppm for 1H NMR, δ 
= 77.0 ppm for 13C-NMR). The following abbreviations are used to indicate signal 
multiplicity: s, singlet; d, doublet; t, triplet; m, multiplet; br, broad. Enantiomeric 
excesses were determined by chiral HPLC using a Shimadzu LC-20AD HPLC 
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equipped with a Shimadzu SPD-M20A diode array detector and columns (Chiralpak 
AD-H and OD-H) provided by Daicel corporation, in comparison with the 
corresponding enantiomers and racemic mixtures. Racemic products were obtained by 
the same procedure as used for the enantioselective 1,2-addition, but omitting the 
ligand and CuBr•SMe2 and only using Grignard reagent (1.2 eq) at 0 °C in Et2O. 
Regioselectivities were determined by 1H-NMR. Optical rotations were measured on a 
Schmidt + Haensch polarimeter (Polartronic MH8) with a 10 cm cell (c given in g/100 
mL) at 20 °C. Thin-layer chromatography (TLC) was performed on Merck TLC Silica 
gel 60 Kieselguhr F254. Flash chromatography was performed on silica gel Merck 
Type 9385 230-400 mesh. Mass spectra were recorded on an LTQ Orbitrap XL (ESI+ 
or APCI+). Copper salts were purchased from Aldrich, and used without further 
purification. All starting materials and ligands were purchased from Aldrich. All 
Grignard reagents were prepared from the corresponding alkyl bromides and Mg 









1,4-Dimethoxy-2,3-dimethylbenzene (16). To a suspension of NaH (60% in mineral 
oil, 8.69 g, 217 mmol) in DMF (150 mL) was added 2,3-dimethylhydroquinone (10.0 
g, 72.4 mmol). The mixture was stirred for 10 min and then cooled to 0 ºC. 
Subsequently, MeI (10.4 mL, 167 mmol) was added dropwise at 0 ºC. The resulting 
mixture was stirred at 0 ºC for 30 min and 3 h at room temperature. Then the mixture 
was poured into 500 mL water and filtered. The obtained wet solid was dissolved in 
Et2O and the organic phase was separated, dried over MgSO4 and concentrated in 
vacuo. The crude product was used for the next step without further purification. 1H 










17 (93% over two steps)  
2,5-Dimethoxy-3,4-dimethylbromobenzene (17). To a solution of 16 (crude product 
from the previous step) in dry CH2Cl2 (50 mL) was added NBS (13.3 g, 74.6 mmol). 
The mixture was stirred at reflux for 6 h. The mixture was allowed to cool down and 




filtered and evaporated in vacuo. The crude product was purified by chromatography 
on silica gel (pentane/EtOAc = 50 : 1) to afford 17 (16.5 g, 93%) as a light yellow 
solid. 1H NMR (400 MHz, CDCl3) δ 6.87 (s, 1 H), 3.78 (s, 3 H), 3.73 (s, 3 H), 2.24 (s, 
3 H), 2.09 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 154.1, 149.0, 132.4, 126.0, 113.3, 










−78 oC, 0.5 h
18 (92%)  
2,5-Dimethoxy-3,4-dimethylbenzaldehyde (18). To a solution of 17 (15.0 g, 61.2 
mmol) in dry THF (80 mL) was added nBuLi (36.7 mL, 91.8 mmol, 2.5 M in hexanes) 
at – 78 ºC. To the resulting mixture was added DMF (23.7 mL, 306 mmol) slowly 
while maintaining the internal temperature below – 60 ºC. The reaction was allowed 
to warm to rt, quenched with water, and concentrated under reduced pressure. The 
residue was diluted with Et2O, and washed with saturated NaHCO3 (aq), and brine. 
The organic phase was dried over MgSO4, filtered and concentrated in vacuo. The 
crude product was purified by chromatography on silica gel (pentane/Et2O = 8 : 1) to 
afford 18 (10.9 g, 92%) as a white solid. 1H NMR (400 MHz, CDCl3) δ 10.33 (s, 1 H), 














(E)-4-(2,5-Dimethoxy-3,4-dimethylphenyl)-3-buten-2-one (19). To a solution of 18 
(5.28 g, 27.2 mmol) and acetone (19.2 mL) in EtOH (48 mL) was added 1.25 M 
NaOH (aq, 96 mL). The mixture was stirred at rt for 15 min and then diluted with 
water (200 mL). The reaction mixture was subsequently neutralized with 2 M HCl 
(aq). EtOH was evaporated under vacuum and the water phase was extracted with 
Et2O. The combined organic phases were washed with brine, dried over MgSO4, 
filtered and evaporated in vacuo. The crude product was purified by chromatography 
on silica gel (pentane/Et2O = 4 : 1) to afford 19 (6.12 g, 96%) as a yellow solid. 1H 
NMR (400 MHz, CDCl3) δ 7.83 (d, J = 16.4 Hz, 1 H), 6.87 (s, 1 H), 6.68 (d, J = 16.4 
Hz, 1 H), 3.81 (s, 3 H), 3.69 (s, 3 H), 2.40 (s, 3 H), 2.22 (s, 3 H), 2.16 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 198.9, 154.0, 152.1, 139.0, 131.6, 130.6, 127.2, 124.6, 
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105.1, 62.1, 55.7, 27.0, 12.6, 12.5; HRMS (ESI) calcd. for C14H19O3 [M + H]+ 
















DCM : H2O = 5 :1











(Z)-3-Bromo-4-(2,5-dimethoxy-3,4-dimethylphenyl)-3-buten-2-one (13). To a 
suspension of oxone (32.1 g, 52.5 mmol) in dichloromethane (150 mL) and water (30 
mL) was added portion-wise sodium bromide (5.38 g, 52.2 mmol) over 10 min at 0 ºC, 
and the resulting mixture was stirred for an additional 30 min. Then, enone 19 (6.12 g, 
26.1 mmol) was added as the solid, portion-wise over 20 min and the mixture was 
stirred overnight, allowing the reaction to warm to rt. The mixture was poured into 
water and extracted with dichloromethane. The combined organic phases were 
washed with water, dried over Na2SO4, filtered and concentrated in vacuo. The 
residue 20 was dissolved in dry THF (150 mL) and the solution was treated with dry 
triethylamine (10 mL, 72 mmol) added dropwise via syringe over 10 min under 
nitrogen. The mixture was stirred under nitrogen at reflux for an additional 16 h. Then 
the mixture was washed with HCl (aq, 2 M) and brine, dried over Na2SO4, filtered and 
evaporated in vacuo. The residue was purified by column chromatography on silica 
gel (pentane/EtOAc = 30 : 1) to afford the α-bromo-enone 13 as a brown solid and 
(E)-3-Bromo-4-(2,5-dimethoxy-3,4-dimethylphenyl)-3-buten-2-one (13-E) as a 
yellow oil. 13-E was subsequently treated under the conditions mentioned above for 
the conversion of 20 into 13 and this afforded an additional crop of 13. In total, 6.54 g 
of 13 was obtained in an overall yield of 80%. 13: 1H NMR (400 MHz, CDCl3) δ 8.34 
(s, 1 H), 7.61 (s, 1 H), 3.84 (s, 3 H), 3.68 (s, 3 H), 2.61 (s, 3 H), 2.24 (s, 3 H), 2.18 (s, 
3 H); 13C NMR (100 MHz, CDCl3) δ 192.6, 153.3, 152.1, 136.7, 131.0, 130.6, 124.2, 
123.9, 108.4, 62.2, 55.8, 26.7, 12.59, 12.57, ; HRMS (APCI) calcd. for C14H18O379Br 
[M + H]+ 313.0434, found 313.0430. 13-E: 1H NMR (400 MHz, CDCl3) δ 7.44 (s, 1 
H), 6.53 (s, 1 H), 3.74 (s, 3 H), 3.62 (s, 3 H), 2.26 (s, 3 H), 2.19 (s, 3 H), 2.13 (s, 3 H); 
13C NMR (100 MHz, CDCl3) δ 197.1, 153.6, 149.8, 134.0, 131.5, 128.8, 125.3, 121.3, 
108.5, 61.0, 55.7, 28.6, 12.6, 12.4; HRMS (APCI) calcd. for C14H18O379Br [M + H]+ 












































DCM : H2O = 5 :1














1,4-Dimethoxy-2,3,5-trimethylbenzene (34) was prepared starting from 
2,3,5-trimethylhydroquinone 33 following a procedure similar to that for 16. 1H NMR 
(400 MHz, CDCl3) δ 6.53 (s, 1 H), 3.78 (s, 3 H), 3.66 (s, 3 H), 2.28 (s, 3 H), 2.21 (s, 3 











35 (88% over two steps)  
2,5-Dimethoxy-3,4,6-trimethylbromobenzene (35). 35 was prepared from 34 in 88% 
yield over two steps following a procedure similar to that for 17. 1H NMR (400 MHz, 
CDCl3) δ 3.74 (s, 3 H), 3.65 (s, 3 H), 2.35 (s, 3 H), 2.22 (s, 3 H), 2.17 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 153.3, 151.5, 129.9, 129.5, 129.4, 117.6, 60.3, 60.2, 16.5, 










−20 oC, 0.5 h
36 (90%)  
2,5-Dimethoxy-3,4,6-trimethylbenzaldehyde (36). 36 was prepared from 35 in 90% 
yield following a procedure similar to that for 18 except for the reaction temperature 
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which was –20 ºC. 1H NMR (400 MHz, CDCl3) δ 10.47 (s, 1 H), 3.76 (s, 3 H), 3.64 (s, 
3 H), 2.48 (s, 3 H), 2.26 (s, 3 H), 2.20 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 192.8, 
159.0, 153.5, 138.4, 131.0, 129.0, 126.1, 63.2, 60.2, 13.6, 12.8, 12.0; HRMS (APCI) 














(E)-4-(2,5-Dimethoxy-3,4,6-trimethylphenyl)-3-buten-2-one (37) was prepared 
from 36 in 99% yield following a procedure similar to that for 19. 1H NMR (400 MHz, 
CDCl3) δ 7.72 (d, J = 16.4 Hz, 1 H), 6.79 (d, J = 16.4 Hz, 1 H), 3.64 (s, 3 H), 3.60 (s, 
3 H), 2.37 (s, 3 H), 2.32 (s, 3 H), 2.21 (s, 3 H), 2.18 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 199.1, 153.9, 153.3, 138.6, 133.0, 131.6, 128.9, 128.8, 125.6, 60.3, 60.2, 

















DCM : H2O = 5 :1






Dibromide 38 was prepared from 37 following a procedure similar to that for 20. 
Subsequently, 38 was dissolved in EtOH and 2 eq of KOAc was added. The resulting 
mixture was refluxed overnight and concentrated in vacuo. The residue was dissolved 
in CH2Cl2 and washed with brine. The organic layer was dried over Na2SO4, filtered 
and evaporated in vacuo. The residue was purified by column chromatography on 
silica gel (pentane/Et2O = 8 : 1) to afford α-bromo-enone 29 in 36% yield as a light 
yellow solid. 1H NMR (400 MHz, CDCl3) δ 8.11 (s, 1 H), 3.67 (s, 3 H), 3.58 (s, 3 H), 
2.61 (s, 3 H), 2.22 (s, 3 H), 2.18 (s, 3 H), 2.15 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 
192.2, 153.4, 151.1, 140.1, 131.8, 129.6, 128.4, 127.3, 126.7, 60.9, 60.1, 26.9, 13.3, 























































−78 oC to r.t., 3 h
 
2,5-Dihydroxy-3,4-dimethylbenzaldehyde (39). To a solution of 18 (500 mg, 2.57 
mmol) in CH2Cl2 (25 mL) was added BBr3 (2 mL, 21 mmol) slowly at –78 oC. The 
resulting mixture was warmed to rt, stirred for 3 h, and quenched with cold water. The 
organic layer was separated and the aqueous phase was extracted with CH2Cl2. The 
combined organic phases were washed with water, dried over Na2SO4, filtered and 
concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (pentane/Et2O = 2 : 1) to afford 39 (423 mg, 99%) as a brown solid. 1H NMR (400 
MHz, CDCl3) δ 11.00 (s, 1 H), 9.72 (s, 1 H), 6.78 (s, 1 H), 4.76 (s, 1 H), 2.25 (s, 3 H), 
2.20 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 195.5, 154.4, 146.6, 135.3, 126.6, 117.4, 














2,5-Bis(tert-butyldimethylsiloxy)-3,4-dimethylbenzaldehyde (40). To a solution of 
39 (402 mg, 2.42 mmol) in CH2Cl2 (10 mL) were added 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 0.91 mL, 6.05 mmol) and 
tert-butyldimethylchlorosilane (802 mg, 5.32 mmol) at rt. The resulting mixture was 
stirred for 10 min at that temperature, and then washed with water, 0.1 M HCl (aq), 
saturated NaHCO3 (aq) and brine. The organic layer was dried over Na2SO4, filtered 
and concentrated in vacuo. The residue was purified by column chromatography on 
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silica gel (pentane/Et2O = 30 : 1) to afford 40 (945 mg, 99%) as a brown oil. 1H NMR 
(400 MHz, CDCl3) δ 10.22 (s, 1 H), 7.07 (s, 1 H), 2.18 (s, 3 H), 2.14 (s, 3 H), 1.06 (s, 
9 H), 1.01 (s, 9 H), 0.22 (s, 6 H), 0.12 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 190.0, 
151.0, 148.4, 137.6, 130.3, 125.5, 113.0, 25.84, 25.77, 18.5, 18.2, 14.1, 13.8, -4.1, -4.3; 















A solution of 40 (873 mg, 2.21 mmol) and 
l-(triphenylphosphoranylidene)-2-propanone (1.06 g, 3.32 mmol) in toluene was 
stirred and heated to reflux for 2 d. The resulting mixture was filtered through a silica 
gel pad and the filter cake washed with Et2O. The combined solvents were evaporated 
in vacuo and the residue was further purified by column chromatography on silica gel 
(pentane/Et2O = 20 : 1) to afford 41 (627 mg, 65%) as a white solid. 1H NMR (400 
MHz, CDCl3) δ 7.79 (d, J = 16.4 Hz, 1 H), 6.86 (s, 1 H), 6.46 (d, J = 16.4 Hz, 1 H), 
2.37 (s, 3 H), 2.14 (s, 3 H), 2.12 (s, 3 H), 1.08 (s, 9 H), 1.02 (s, 9 H), 0.21 (s, 6 H), 
0.11 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 198.8, 148.2, 147.1, 140.8, 133.0, 129.7, 
125.7, 123.2, 112.8, 26.7, 25.9, 25.8, 18.5, 18.2, 14.4, 13.8, -3.6, -4.2; HRMS (ESI) 























one (28). 28 (36%) was prepared from 41 together with 9% of 28-E following a 
procedure similar to that for 13. 28: 1H NMR (400 MHz, CDCl3) δ 8.15 (s, 1 H), 7.46 
(s, 1 H), 2.56 (s, 3 H), 2.16 (s, 3 H), 2.14 (s, 3 H), 1.05 (s, 9 H), 1.02 (s, 9 H), 0.24 (s, 
6 H), 0.07 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 192.8, 147.5, 147.0, 138.4, 132.7, 
129.1, 122.9, 122.5, 115.7, 26.8, 25.9, 25.8, 18.4, 18.3, 14.3, 13.7, -3.7, -4.3; HRMS 
(ESI) calcd. for C24H42O3Si279Br [M + H]+ 513.1850, found 513.1848; (28-E) 1H 
NMR (400 MHz, CDCl3) δ 7.40 (s, 1 H), 6.45 (s, 1 H), 2.30 (s, 3 H), 2.110 (s, 3 H), 
2.108 (s, 3 H), 1.05 (s, 9 H), 1.00 (s, 9 H), 0.17 (s, 6 H), 0.14 (s, 6 H); 13C NMR (100 




26.0, 25.8, 18.5, 18.2, 14.3, 13.6, -3.5, -4.4; HRMS (ESI) calcd. for C24H42O3Si279Br  







−78 oC 22  
 
(6R, 10R)-6,10,14-Trimethylpentadecan-2-one (22). Through a stirred solution of 
phytol 21 (the natural R,R-isomer, 10.7 g, 36.0 mmol, ≥ 97%, purchased from 
Sigma-Aldrich) in MeOH (20 mL) and CH2Cl2 (110 mL) at –78 oC was bubbled 
ozone over 1 h until a blue color persisted in the solution. Subsequently, nitrogen was 
bubbled through the solution until the blue color disappeared. Me2S (20 mL) was 
added dropwise and the mixture was stirred at rt for 2 h. Volatiles were removed under 
reduced pressure and the residue was divided between water and Et2O. The organic 
phase was separated, washed with brine, dried over MgSO4, and concentrated in 
vacuo. The obtained crude product 22 was used in the next step without further 
purification. 1H NMR (400 MHz, CDCl3) δ 2.40 (t, J = 8.0 Hz, 2 H), 2.13 (s, 3 H), 









r.t., 2 d  
 
(4R,8R)-4,8,12-Trimethyltridecyl acetate (23). To a mixture of 22 from last step and 
sodium percarbonate (90 g, 576 mmol) in CH2Cl2 (600 mL) was added trifluoroacetic 
anhydride (20 mL, 143 mmol). The resulting mixture was stirred vigorously at rt for 
48 h, and subsequently filtered over a Celite pad. The filtrate was neutralized by 
washing with saturated NaHCO3 (aq), and the layers were separated. The aqueous 
layer was back-extracted with Et2O and the combined organic phases were dried over 
MgSO4, filtered and evaporated in vacuo. The obtained crude product 23 was used in 
the next step without further purification. 1H NMR (400 MHz, CDCl3) δ 4.04 (t, J = 
8.0 Hz, 2 H), 2.04 (s, 3H), 1.62-1.04 (m, 19 H), 0.87-0.83 (m, 12 H). 
 
O







(4R, 8R)-4,8,12-Trimethyltridecan-1-ol (24). To a solution of 23 from last step in a 
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mixture of THF (150 mL), MeOH (150 mL) and water (75 mL) was added LiOH 
(1.12 g, 46.8 mmol). The mixture was stirred at rt for 2 h. Then the mixture was 
neutralized with HCl (1 M) and the organic solvents were removed in vacuo. The 
aqueous layer was extracted with Et2O and the combined organic phases were dried 
over MgSO4, filtered and evaporated in vacuo. The residue was purified by column 
chromatography on silica gel (pentane/EtOAc = 20 : 1) to afford alcohol 24 (8.03 g, 
92% over 3 steps) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 3.63 (t, J = 6.4 Hz, 







0 oC, 2 h
 
 
(4R,8R)-1-Bromo-4,8,12-trimethyltridecane (25). To a solution of 24 (2.11 g, 8.7 
mmol) and PPh3 (2.74 g, 10.4 mmol) in CH2Cl2 (20 mL) was added 
N-bromosuccinimide (1.75 g, 9.8 mmol, 1.1 eq) at 0 oC over 10 min. The reaction was 
stirred for 2 h and concentrated in vacuo. To the solid/liquid residue was added 
hexane (20 mL), solids were removed by filtration and washed with hexane. The 
concentrated filtrate was purified by chromatography on silica gel (hexane) to afford 
25 (2.03 g, 76%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 3.39 (dt, J = 6.8 Hz, 










(4R,8R)-4,8,12-Trimethyltridecanylmagnesium bromide (14). A Schlenk tube 
equipped with stirring bar was charged with magnesium turnings (190 mg, 7.9 mmol) 
and a crystal of iodine. The tube was heated until the iodine had decolorized and after 
cooling back to rt, 2 mL of dry Et2O was added and the resulting suspension was 
stirred under nitrogen. 25 (2.01 g, 6.6 mmol) was dissolved in Et2O (2.4 mL) and 
added to the Schlenk tube at 0 oC at such a rate that the suspension maintained a 
gentle reflux. The mixture was subsequently allowed to come to rt and was stirred for 
2 h to afford 14. The concentration was determined to be 1.47 M by a titration with 




















phenyl)-hexadecen-3-ol (26) A Schlenk tube equipped with septum and stirring bar 
was charged with CuBr·SMe2 (16.4 mg, 0.080 mmol, 5 mol%) and ligand L9 (52.1 
mg, 0.096 mmol, 6 mol%). Under nitrogen, dry tBuOMe (8 mL) was added and the 
solution was stirred at rt for 15 min. Then 13 (500 mg, 1.60 mmol, in 5 mL tBuOMe) 
was added and the resulting solution was cooled to –78 oC. The corresponding 
Grignard reagent 14 (1.30 mL, 1.92 mmol, 1.47 M in Et2O) was diluted with tBuOMe 
(2 mL) and added to the reaction mixture over 3 h with a syringe pump. Stirring was 
continued overnight at –78 oC. The reaction was quenched by the addition of MeOH 
and saturated aqueous NH4Cl before the mixture was warmed to rt. Et2O was added to 
the mixture and the organic layer was separated. The aqueous layer was extracted with 
Et2O and the combined organic phases were dried over anhydrous Na2SO4, filtered 
and evaporated in vacuo. The residue was purified by column chromatography on 
silica gel (pentane/EtOAc = 20 : 1) to afford alcohol 26 (803 mg, 93%) as a light 
yellow oil. According to chiral HPLC (OD-H column, heptane/i-PrOH 98:2, 40 °C, 
256 nm) the d.e. was 73%. Retention time: tmajor = 23.1 and tminor = 30.6 min. [α]20D = 
+3.9 (c 0.93, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.27 (s, 1 H), 7.05 (s, 1 H), 3.82 
(s, 3 H), 3.63 (s, 3 H), 2.22 (s, 3 H), 2.16 (s, 3 H), 2.14 (brs, 1 H), 1.92-1.70 (m, 2 H), 
1.59 (s, 3 H), 1.56-1.50 (m, 1 H), 1.44-1.04 (m, 18 H), 0.88-0.84 (m, 12 H); 13C NMR 
(100 MHz, CDCl3) δ 153.1, 150.3, 135.20, 130.5, 126.8, 126.7, 123.4, 109.4, 77.1, 
61.2, 55.9, 41.4, 39.4, 37.44, 37.40, 37.3, 37.2, 32.8, 32.7, 28.0, 27.5, 24.8, 24.5, 22.7, 
22.6, 21.5, 19.74, 19.67, 12.5, 12.2; HRMS (APCI) calcd. for C30H5081BrO2 [M - 
















adecen-3-ol (31) To a solution of 26 (300 mg, 0.56 mmol) in Et2O was slowly added a 
solution of tBuLi (0.82 mL, 1.40 mmol, 1.7 M in pentane) under nitrogen at –78 oC, 
and the resulting mixture was stirred at this temperature for 30 min. Then the reaction 
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was quenched with MeOH and saturated aqueous NH4Cl. The mixture was warmed to 
rt and diluted with Et2O. The organic layer was separated. The aqueous layer was 
extracted with Et2O and the combined organic phases were dried over Na2SO4, 
filtered and evaporated in vacuo. The residue was purified by column chromatography 
on silica gel (pentane/EtOAc = 15 : 1) to afford alcohol 31 (235 mg, 91%) as a light 
yellow oil. [α]20D = +7.5 (c 0.64, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.84 (d, J = 
16.0 Hz, 1 H), 6.79 (s, 1 H), 6.26 (d, J = 16.0 Hz, 1 H), 3.82 (s, 3 H), 3.65 (s, 3 H), 
2.21 (s, 3 H), 2.14 (s, 3 H), 1.66-1.61 (m, 3 H), 1.56-1.49 (m, 1 H), 1.44-1.05 (m, 18 
H), 1.41 (s, 3 H), 0.88-0.83 (m, 12 H); 13C NMR (100 MHz, CDCl3) δ 153.9, 150.0, 
137.0, 131.0, 127.2, 126.2, 122.3, 105.2, 73.4, 61.0, 55.8, 43.2, 39.4, 37.6, 37.42, 
37.38, 37.3, 32.79, 32.77, 28.2, 28.0, 24.8, 24.5, 22.7, 22.6, 21.6, 19.73, 19.65, 12.5, 
















adecan-3-ol (32)  To a vigorously stirring solution of 31 (155 mg, 0.34 mmol) in 
EtOH (5 mL) was added a solution of flavin catalyst (206 mg, 0.51 mmol) in EtOH 
(0.50 mL) and hydrazine hydrate (0.33 mL, 6.8 mmol) over 10 min under an 
atmosphere of oxygen. The resulting mixture was stirred overnight. Subsequently 
CH2Cl2 was added and the mixture was washed with water. The organic phase was 
dried over MgSO4, filtered and evaporated in vacuo. The residue was purified by 
column chromatography on silica gel (pentane/Et2O = 5 : 1) to afford alcohol 32 (142 
mg, 90%) as a colorless oil. [α]20D = +2.7 (c 0.67, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 6.54 (s, 1 H), 3.79 (s, 3 H), 3.68 (s, 3 H), 2.69-2.65 (m, 2 H), 2.21 (s, 3 H), 
2.12 (s, 3 H), 1.78-1.73 (m, 2 H), 1.54-1.49 (m, 4 H), 1.44-1.05 (m, 18 H), 1.25 (s, 3 
H), 0.88-0.84 (m, 12 H); 13C NMR (100 MHz, CDCl3) δ 153.7, 150.2, 132.5, 130.8, 
124.1, 109.2, 72.7, 60.9, 55.8, 43.2, 42.4, 39.4, 37.8, 37.44, 37.40, 37.3, 32.81, 32.79, 
28.0, 26.9, 24.9, 24.8, 24.5, 22.7, 22.6, 21.5, 19.74, 19.67, 12.8, 11.9; HRMS (APCI) 





















γ-Tocopherol To a solution of 32 (45 mg, 0.097 mmol) in CH3CN (3 mL) was added 
a solution of cerium (IV) ammonium nitrate (159 mg, 0.29 mmol) in CH3CN/H2O (3 
mL/3 mL) at 0 oC. The resulting mixture was stirred at this temperature for 2 h and 
subsequently CH2Cl2 (15 mL) was added. The organic layer was separated and the 
aqueous phase was extracted with CH2Cl2. The combined organic phases were dried 
over MgSO4, filtered and evaporated in vacuo. The crude product was dissolved in 
acetone (20 mL) without further purification, and an aqueous solution of Na2S2O4 
(1.15 g in 10 mL water) was added. The mixture was stirred at rt for 30 min, and then 
extracted with CH2Cl2. The combined organic phases were dried over MgSO4, filtered 
and evaporated in vacuo. The crude product was immediately dissolved in dry toluene 
(10 mL), and the resulting solution heated to 65 oC followed by addition of 
p-toluenesulfonic acid monohydrate (5 mg). The mixture was stirred at this 
temperature for 30 min, and was then concentrated in vacuo. The residue was purified 
by column chromatography on silica gel (pentane/Et2O = 10 : 1) to afford 
γ-tocopherol (29 mg, 72%) as a brown oil. [α]20D = +1.8 (c 1.44, CHCl3); [α]20D = 
+1.5 (c 1.18, EtOH); 1H NMR (400 MHz, CDCl3) δ 6.37 (s, 1 H), 4.25 (br s, 1 H), 
2.69-2.65 (m, 2 H), 2.14 (s, 3 H), 2.12 (s, 3 H), 1.78-1.69 (m, 2 H), 1.58-1.50 (m, 3 H), 
1.47-1.04 (m, 18 H), 1.25 (s, 3 H), 0.88-0.84 (m, 12 H); 13C NMR (100 MHz, CDCl3) 
δ 146.2, 145.7, 125.8, 121.6, 118.3, 112.1, 75.5, 40.1, 39.4, 37.6, 37.5, 37.4, 37.3, 
32.8, 32.7, 31.3, 28.0, 24.8, 24.4, 24.1, 22.7, 22.6, 22.3, 21.0, 19.74, 19.68, 11.90, 
11.86; HRMS (ESI) calcd. for C28H48O2 [M] 416.3649, found 416.3640; C28H49O2 [M 
+ H]+ 417.3682, found 417.3677. 1H NMR and 13C NMR are identical to the disclosed 


















phenyl)-hexadecen-3-ol (30). 30 was prepared from 29 in 21% yield according to the 
procedure for the preparation of 26 and meanwhile 37% of starting material was 
recycled. 1H NMR (400 MHz, CDCl3) δ 7.07 (s, 1 H), 3.67 (s, 3 H), 3.61 (s, 3 H), 
2.21 (s, 3 H), 2.18 (s, 3 H), 2.15 (s, 3 H), 1.94-1.85 (m, 1 H), 1.77-1.69 (m, 1 H), 1.58 
(s, 3 H), 1.54-1.49 (m, 1 H), 1.43-1.08 (m, 19 H), 0.88-0.84 (m, 12 H); 13C NMR (100 
MHz, CDCl3) δ 153.1, 151.5, 130.1, 129.3, 128.0, 127.2, 124.3, 76.9, 60.5, 60.1, 41.4, 
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39.4, 37.43, 37.38, 37.3, 37.2, 32.79, 32.77, 28.0, 27.7, 24.8, 24.5, 22.7, 22.6, 21.3, 
19.74, 19.67, 13.1, 12.8, 12.5; HRMS (ESI) calcd. for C31H53O379BrNa [M + Na]+ 





















l (27). 27 was prepared from 13 in 90% yield following a procedure similar to that for 
26. According to chiral HPLC (OD-H column, heptane/i-PrOH 98:2, 40 °C, 256 nm) 
the ee was 87%. Retention time: tmajor = 27.6 and tminor = 34.8 min; 1H NMR (400 
MHz, CDCl3) δ 7.33 (s, 1 H), 7.06 (s, 1 H), 3.82 (s, 3 H), 3.63 (s, 3 H), 2.22 (s, 3 H), 
2.17 (br s, 1 H), 2.16 (s, 3 H), 1.90-1.80 (m, 2 H), 1.70-1.65 (m, 1 H), 1.60 (s, 3 H), 
1.04-0.99 (m, 6 H); 13C NMR (100 MHz, CDCl3) δ 153.1, 150.4, 135.4, 130.5, 126.8, 
126.7, 123.1, 109.4, 77.6, 61.1, 55.9, 49.1, 28.7, 24.6, 24.5, 24.3, 12.5, 12.2; 





Mg neopentyl2PClEt2O  
 
Bisneopentylphosphorus chloride. 4.5 mL of neopentyl chloride and 1.05 g of 
magnesium were used to prepare neopentylmagnesium chloride in 18 mL of diethyl 
ether. The resulting Grignard reagent was cooled down to 0 oC and 0.88 mL of PCl3 
was added slowly. After heating at reflux for 4 h, the mixture was stirred overnight at 















(S)-N,N-Dimethyl-1-[(R)-2-(dineopentylphosphino)ferrocenyl]ethylamine (43). To 




in Et2O (4 mL) was added sec-BuLi (1.4 M in cyclohexane, 0.45 mL) at rt. The 
resulting mixture was stirred for 2 h at rt and the freshly made bisneopentyl 
phosphorus chloride (0.60 g, >>2 eq.) was added. The mixture was heated under 
reflux for 2.5 h and subsequently cooled down to 0 oC. Saturated NaHCO3 (aq) was 
added slowly, and the organic layer was separated. The aqueous layer was extracted 
with toluene. The combined organic phases were dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was partly purified by quick column 
chromatography on silica gel (CH2Cl2/MeOH = 10 : 1) and the obtained crude product 















(S)-1-[(R)-2-(Dineopentylphosphino)ferrocenyl]ethyldiphenylphosphine (L7). To 
a solution of 43 (147 mg) in anhydrous and degassed acetic acid was added 
diphenylphosphine (0.06 mL, 0.34 mmol). The resulted mixture was stirred for 3 h at 
80 oC. The acetic acid was removed in vacuo and the residue was partly purified by 
quick column chromatography on silica gel (CH2Cl2/MeOH = 10 : 1). The obtained 
crude product (103 mg) was dissolved in CH2Cl2 and CuBr⋅SMe2 (31 mg) was added 
portion-wise to get a clear solution. The solvent was removed in vacuo. The residue 
was recrystallized in cyclohexane and afforded L7 (72 mg, 21% from 42) as an 
orange powder. 1H NMR (400 MHz, CDCl3) δ 7.60-7.56 (m, 2 H), 7.40-7.29 (m, 4 H), 
7.20-7.17 (m, 4 H), 4.39 (s, 1 H), 4.21 (s, 5 H), 4.13 (s, 1 H), 3.90 (s, 1 H), 3.50-3.44 
(m, 1 H), 2.33-2.19 (m, 4 H), 1.49 (t, J = 8.0 Hz, 3 H), 1.22 (s, 9 H), 1.18 (s, 9 H); 13C 
NMR (100 MHz, CDCl3) δ 135.1, 135.0, 132.6, 132.5, 130.3 (d), 129.3, 128.8, 128.7, 
128.1, 128.0, 72.8 (d), 70.5 (d), 69.0, 67.2 (d), 50.8 (d), 42.3 (t), 32.1 (d), 31.6 (m), 
14.3; 31P NMR (133 MHz, CDCl3) δ -8.27 (d, J = 146.3 Hz), -46.33 (d, J = 146.4 Hz); 
HRMS (APCI) calcd. for C34H34CuFeP2 [M - Br]+ 633.1558, found 633.1560. 
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